Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/4549
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDegirmenci, Eylem-
dc.contributor.authorŞahiner, Türker-
dc.contributor.authorErdogan, Çağdaş-
dc.contributor.authorÖzdemir, Fatma-
dc.contributor.authorGür, Selahattin-
dc.contributor.authorŞahiner, Ayşe Melike-
dc.date.accessioned2019-08-16T11:34:53Z-
dc.date.available2019-08-16T11:34:53Z-
dc.date.issued2006-
dc.identifier.issn1017-7833-
dc.identifier.urihttps://hdl.handle.net/11499/4549-
dc.description.abstractObjective: Influence of piracetam in post-stroke aphasia and myoclonic epilepsy has been shown with EEG spectral power analysis. Particularly piracetam is involved in restoration of alpha topography in these patients. On the other hand long term effects of piracetam in Alzheimer's disase or minimal cognitive impairment (MCI) patients have not been determined so far. Methods: We have evaluated spectral EEG analysis of 13 minimal cognitive impairment and 18 mild or less severe Alzheimer dementia patients after receiving piracetam 2400 mg and 4800 mg respectively for 4 weeks. Control group was consisted of 16 healthy subjects with similar age and sex characteristics. We analyzed EEG power spectrum before and after delivering 2400 or 4800 mg piracetam. Results: In Alzheimer's disase group enhancement of delta band power began with 2400 mg piracetam and lasted on 4800 mg. Theta band power spectrum values significantly decreased. Alpha and beta band power spectrums were not changed. MCI patients have shown very similar results with AD patients Conclusions: We have found that long term delivering of piracetam enhances slow-wave band powers of EEG both in Alzheimer's disase and MCI patients.en_US
dc.language.isoenen_US
dc.relation.ispartofKlinik Psikofarmakoloji Bultenien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAlzheimer's diseaseen_US
dc.subjectMinimal cognitive impairmenten_US
dc.subjectPiracetamen_US
dc.subjectSpectral EEGen_US
dc.subjectpiracetamen_US
dc.subjectadulten_US
dc.subjectAlzheimer diseaseen_US
dc.subjectarticleen_US
dc.subjectclinical articleen_US
dc.subjectcontrolled studyen_US
dc.subjectdemographyen_US
dc.subjectelectroencephalogramen_US
dc.subjectfemaleen_US
dc.subjecthumanen_US
dc.subjectlong term careen_US
dc.subjectmaleen_US
dc.subjectpower spectrumen_US
dc.subjecttheta rhythmen_US
dc.titleLong term effects of piracetam on spectral analysis of EEG in Alzheimer's disease and minimal cognitive impairmenten_US
dc.typeArticleen_US
dc.identifier.volume16en_US
dc.identifier.issue2en_US
dc.identifier.startpage93-
dc.identifier.startpage93en_US
dc.identifier.endpage97en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopus2-s2.0-33745892384en_US
dc.identifier.scopusqualityQ4-
dc.ownerPamukkale_University-
item.languageiso639-1en-
item.openairetypeArticle-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection
Files in This Item:
File SizeFormat 
d1c1ad1e-7399-4fdf-ac21-f9ee5193f79a.pdf168.38 kBAdobe PDFView/Open
Show simple item record



CORE Recommender

SCOPUSTM   
Citations

2
checked on Jun 29, 2024

Page view(s)

66
checked on May 27, 2024

Download(s)

192
checked on May 27, 2024

Google ScholarTM

Check





Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.